DE2139082A1 - Substituierte pyrimidine, verfahren zu deren herstellung und sie enthaltende arzneimittel - Google Patents

Substituierte pyrimidine, verfahren zu deren herstellung und sie enthaltende arzneimittel

Info

Publication number
DE2139082A1
DE2139082A1 DE19712139082 DE2139082A DE2139082A1 DE 2139082 A1 DE2139082 A1 DE 2139082A1 DE 19712139082 DE19712139082 DE 19712139082 DE 2139082 A DE2139082 A DE 2139082A DE 2139082 A1 DE2139082 A1 DE 2139082A1
Authority
DE
Germany
Prior art keywords
group
methyl
hydrogen atom
atom
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712139082
Other languages
German (de)
English (en)
Inventor
Kurt Dipl Chem Dr Klemm
Wolfgang Dipl Chem Dr Pruesse
Wolfgang Dr Med Schoetensack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE787125D priority Critical patent/BE787125A/xx
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Priority to DE19712139082 priority patent/DE2139082A1/de
Priority to LU65836A priority patent/LU65836A1/xx
Priority to FR7227858A priority patent/FR2150722A1/fr
Priority to NL7210636A priority patent/NL7210636A/xx
Priority to JP7799272A priority patent/JPS4826777A/ja
Publication of DE2139082A1 publication Critical patent/DE2139082A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19712139082 1971-08-04 1971-08-04 Substituierte pyrimidine, verfahren zu deren herstellung und sie enthaltende arzneimittel Pending DE2139082A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BE787125D BE787125A (fr) 1971-08-04 Pyrimidines substituees, leurs procedes de preparation et medicaments les contenant
DE19712139082 DE2139082A1 (de) 1971-08-04 1971-08-04 Substituierte pyrimidine, verfahren zu deren herstellung und sie enthaltende arzneimittel
LU65836A LU65836A1 (ja) 1971-08-04 1972-08-01
FR7227858A FR2150722A1 (en) 1971-08-04 1972-08-02 Substd pyrimidines - hypotensives and analgesics
NL7210636A NL7210636A (ja) 1971-08-04 1972-08-03
JP7799272A JPS4826777A (ja) 1971-08-04 1972-08-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712139082 DE2139082A1 (de) 1971-08-04 1971-08-04 Substituierte pyrimidine, verfahren zu deren herstellung und sie enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DE2139082A1 true DE2139082A1 (de) 1973-02-15

Family

ID=5815787

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712139082 Pending DE2139082A1 (de) 1971-08-04 1971-08-04 Substituierte pyrimidine, verfahren zu deren herstellung und sie enthaltende arzneimittel

Country Status (6)

Country Link
JP (1) JPS4826777A (ja)
BE (1) BE787125A (ja)
DE (1) DE2139082A1 (ja)
FR (1) FR2150722A1 (ja)
LU (1) LU65836A1 (ja)
NL (1) NL7210636A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
WO1996002519A1 (de) * 1994-07-15 1996-02-01 Basf Aktiengesellschaft Substituierte pyrimidinverbindungen und deren verwendung

Also Published As

Publication number Publication date
LU65836A1 (ja) 1973-08-17
FR2150722A1 (en) 1973-04-13
NL7210636A (ja) 1973-02-06
JPS4826777A (ja) 1973-04-09
BE787125A (fr) 1973-02-05

Similar Documents

Publication Publication Date Title
DE2366106C2 (de) 2-Amino-6,7-dimethoxy-4-(methoxysubstituierte-lÄ3»4-tetrahydroisochinolin-2-yl)-chinazolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2504565A1 (de) Neue derivate von 1h-imidazo(4,5-c) pyridin-7-carboxylsaeuren und -saeureestern
DD141520A5 (de) Verfahren zur herstellung neuer derivate von 4-amino-5-alkylsulfonyl-ortho-anisamiden
DE2226703A1 (de) Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
EP0163260A1 (de) Neue substituierte Pyrrolidinone, Verfahren zu ihrer Herstellung und Arzneimittel
DE2604748A1 (de) Aminoderivate von imidazo(4,5-b) pyridinen
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
WO2002020491A1 (de) Arylpiperazinderivate und deren verwendung als psychopharmaka
EP0180115A2 (de) 1,2,4-Triazolo-carbamate und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE2658558A1 (de) Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2726820A1 (de) Imidazothiazine
DE2431609A1 (de) Neue sulfamoylbenzoesaeureamide
DE2609210A1 (de) Substituierte piperazinyliminorifamycine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2143730A1 (de) Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE3427985A1 (de) Neue 2h-l-benzopyran-2-on-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
EP0124630B1 (de) Pyrimidin-Thioalkylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindung enthaltende Arzneimittel
DE2139082A1 (de) Substituierte pyrimidine, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2139083A1 (de) Substituierte pyrimidine, verfahren zu deren herstellung und sie enthaltende arzneimittel
EP0088323B1 (de) Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE2258403A1 (de) Basisch substituierte chinazolon-(2)derivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
EP0212551B1 (de) Neue Tetraoxoverbindungen
EP0206155B1 (de) Neue aromatische Verbindungen, ihre Herstellung und Verwendung
DE2600325A1 (de) Butazonderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
EP0342536A1 (de) Thienyl-Piperazinone, ihre Herstellung und Verwendung
DE1620368A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen